News by subject: HEALTH

Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today announced the medical journal JAMA Neurology has published peer-reviewed efficacy and safety results from the X-TOLE Phase 2b randomized clinical trial of XEN1101, a...

DIAGNOS Inc. ("DIAGNOS" or the "Corporation") , a Canadian corporation active in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is thrilled to announce the commencement of its...

Redsense Medical AB , based in Sweden, focused on monitoring of blood leakage during hemodialysis to increase patient safety, today announced that Pontus Nobréus, CEO, will present live at the Small Cap Growth Virtual Investor Conference, hosted by...

Biomea Fusion, Inc. ("Biomea") , a clinical-stage...

RTOERO representatives met with Ontario MPPs and government officials yesterday for the organization's seventh annual Vibrant Voices advocacy event to discuss issues concerning seniors, geriatric health care and the environment.  Starting off the...

Theratechnologies Inc. ("Theratechnologies" or the "Company") , a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the U.S. Food and Drug Administration...

Policane®, a natural sweetener made from sugar cane juice in a patented process, has been found to have a low glycemic index (GI) in a study by IFP Suisse SA. According to the study Policane® has a GI of 51.7+/- 3.66. The study also found that...

DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") , a generative artificial intelligence healthcare company, announced today the launch of CERVAItm Healthcare Provider Network, a partnership program to expand access to the Company's brain...

Solomon Partners, a leading financial advisory firm, announced that it has appointed Karan Garg (KG) as Head of Healthcare Services in the firm's Healthcare Group and has also hired Brad Hildebrand as a Managing Director focused on Healthcare...

Nathan Cafferky, M.D., FAAOS (Fellow of the American Academy of Orthopaedic Surgeons), will join The Steadman Clinic's orthopaedic surgical team on Oct. 16, 2023. Dr. Cafferky joins The Steadman Clinic's Drs. Raymond Kim and Joel Matta in the...

More than two years after the publication of landmark Canadian clinical practice guidelines for treating obesity in adults, many patients receiving care for a range of common diseases often attributable to excess weight report they are not being...

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced it is joining patient advocacy organizations, including the National...

In the heart of Canada, where the land stretches far and wide, LifeLabs is fostering a legacy of compassion and support for Indigenous communities. As we reflect and commemorate the National Day for Truth and Reconciliation, it's a moment to...

Biogen Inc.  announced that the U.S. Food and Drug Administration (FDA) has approved TOFIDENCE (tocilizumab-bavi) intravenous formulation, a biosimilar monoclonal antibody referencing...

On September 30, 2023, Canada's leading occupational therapy organizations reaffirmed their dedication to Indigenous Peoples in Canada through addressing the Truth and Reconciliation Commission (TRC) of Canada's Calls to Action with the announcement...

Medicenna Therapeutics Corp. ("Medicenna" or "the Company") , a clinical-stage immunotherapy company focused on the development of novel Superkines, announced that the Company will present preclinical results featuring its MDNA223 BiSKIT candidate at...

XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the acceptance of an abstract submitted to the...

Helius Medical Technologies, Inc. ("Helius" or the...

September 28, 2023: The Society of Obstetricians and Gynaecologists of Canada (SOGC) will hold its conference, FMC Québec 2023, from September 28 to 29 in Trois-Rivières. The two-day conference will feature panels, workshops and a multitude of...

A new study of 18,097 people across 18 countries has discovered that...

PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") , a commercial-focused specialty pharmaceutical company, today announced the U.S. Food and Drug Administration ("FDA") has accepted the Abbreviated New Drug Application ("ANDA") for KETARXtm...

Today, Mr. George Chahal, Liberal Member of Parliament for Calgary Skyview, will be making a statement to the House of Commons on the benefits of universal access to contraception in Canada. Last week, the issue was brought forth by members of the...

Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare genetic diseases, today announced the approval of Evkeeza® (evinacumab) in Canada. Evkeeza® was...

Extended wait times for screening, diagnostics and treatment for children can have severe repercussions on the health and well-being outcomes for Canada's youth. No Child Elects to Wait, a new report for Children's Healthcare Canada (CHC) by The...

Nymox Pharmaceutical Corporation [OTC Markets ? NYMXF] (the "Company") is pleased to announce today that a new formal submission has been made by the Company in the U.K. for Nymozarfex (TM) for the treatment of benign prostatic hyperplasia (BPH). The...

TELUS Health today released its monthly TELUS Mental Health Index, revealing that two-in-five workers in Canada are unfamiliar with the purpose of an Employee Assistance Program (EAP) - also known as an Employee and Family Assistance Program (EFAP) -...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that humanized anti- soluble aggregated amyloid-beta (A?) monoclonal antibody LEQEMBI® Intravenous Infusion (200 mg, 500mg, lecanemab) has been approved...

On the evening of September 19, 2023, the Fatty Liver Alliance, a Canadian not-for-profit charity, hosted, at the Westmount Public Library, in Westmount, Quebec, an extraordinary event that saw an overwhelming turnout of 50 community members. The...

Arch Biopartners Inc., ("Arch" or the "Company") , announced that it has submitted applications to the Ministry of Health (MoH) and local Ethics Committee in Turkey to obtain permission to proceed with a Phase II trial for LSALT peptide, targeting...

The Canadian Occupational Therapists Foundation (COTF) and the Canadian Association of Occupational Therapists (CAOT) have partnered with Gowan Consulting to announce the New Gowan Health Indigenous Scholarship to support Indigenous people pursuing...

Supported by the Canada Brain Research Fund and anchored by a lead gift from the Azrieli Foundation, the Future Leaders in Canadian Brain Research program aims to accelerate novel and transformative research that will fundamentally change our...

LSL Pharma Group Inc. ? (the "Company" or "LSL Pharma Group"), a Canadian integrated pharmaceutical company, announced today that it has entered into an agreement with iA Capital Markets as the sole agent and sole bookrunner ("Agent"), in connection...

In a study published online in CELL today, scientists at UCSF QBI, University College London and the...

via InvestorWire ? Genprex Inc. today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork ("IBN"), a multifaceted financial news and publishing company for private...

IntelGenx Corp. (the "Company" or "IntelGenx") today announced that it has received the first purchase order ("PO") for RIZAFILM®1 from its commercial partner in the United States, Gensco Pharma ("Gensco®"). The PO triggers an upfront order deposit...

The people of Ontario have built up our local public hospitals and their services over 100 years. For more than 50 years, for-profit hospitals have been banned in our province. Now, the Ford government is dismantling our local public hospitals in a...

Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that it will exhibit at the Academy of Neurologic...

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced it is joining the global narcolepsy advocacy community, including more...

The families of innocent victims killed in impaired driving crashes will come together on Saturday for a special Ceremony of Hope and Dedication at MADD Canada's Alberta Memorial Monument. The beautiful Monument, located at the Parkland RCMP...

Theratechnologies Inc. ("Theratechnologies" or the "Company") , a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Mr. Paul Lévesque, President and Chief Executive Officer, will...

Today, the President of The Society of Obstetricians and Gynaecologists of Canada (SOGC), Dr. Amanda Black, will be attending a Day of Representation on Parliament Hill to champion the economic and social benefits of free and Universal access to...

IntelGenx Corp. (the "Company" or "IntelGenx") today provided a regulatory update on Buprenorphine Buccal Film, for which an abbreviated new drug application ("ANDA") has been filed with the U.S. Food and Drug Administration ("FDA" or the "Agency")...

Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure, announced new leadership appointments, including Jason Spees to Chief Executive Officer, Shlomi Nachman to Chairman of the Board, and...

Harvard Bioscience, Inc. and Etisense announced today that they have entered into an agreement to offer DECRO®, Etisense's non-invasive telemetry jacket and...

Aptose Biosciences Inc. ("Aptose" or the "Company") , a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced that the Aptose management team will...

Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to developing innovative and patented therapeutic solutions for underserved mental health conditions today announced that the U.S. Food and Drug Administration (FDA) has...

Avricore Health Inc.  ("Avricore Health" or the "Company") is expanding its innovative point-of-care chronic and infectious disease screening and health-data management platform, HealthTabtm, further into the Canadian pharmacy ecosystem with one of...

Optimi Health Corp. (FRA: 8BN), a Canadian psychedelics drug research and formulation company, is pleased to see the positive and encouraging outcomes from the MAPS Phase 3 MDMA-Assisted Therapy (MDMA-AT) Clinical Trial published today on Nature...

Ahead of National Physician Suicide Awareness Day on September 17, Disappearing Doctors ? a global coalition of organizations founded by FCB Health New York, an IPG Health company ? dedicated to advocating for and providing mental health support to...

Malia Cali, MD, will join The Steadman Clinic's medical team in September. Dr. Cali, physiatrist who specializes in interventional spine and sports medicine will work from The Steadman Clinic's Frisco location. She officially joins the team on Sept....